The "hyaluronic acid leader" Bloomage Biotech (688363) is starting an internal governance.

On the evening of March 3, Bloomage Biotech's WeChat public account released the full text of the speech of Zhao Yan, chairman of the company, at the president's office meeting. Among them, her proposal that "all corrupt personnel, regardless of their positions, must explain their problems and submit their resignations within a limited time before March 31" has attracted attention from the outside world.

began to focus on "human transformation".

It is reported that Zhao Yan's speech was themed on "strictly governing the organization, returning to the front line of business, and returning to the entrepreneurial state". She said that in 2024, the company will enter a period of change and adjustment, and the first stage of the company will focus on the adjustment of the process. Process adjustment is just to correct the company's out-of-control actions, exposing many problems that were not exposed before, and the real change is the change of people, which is just beginning.

Zhao Yan bluntly said that the rapid development brings abundant financial resources and influence resources, but also makes the team quickly lose the ability to solve problems in the entrepreneurial state of scarce resources and thinking ability, when encountering problems and difficulties, not to find a way to solve them, but layer by layer, and then through budget outsourcing to do a lot of pseudo work, the formation of a situation that can not do anything without a large budget, but also breeds corruption, self-interest, take easy shortcuts of the idea.

"The reason why we first adjusted the process and took back a lot of the financial approval power of outsourcing in this round of reform is because the company's strategy has not been implemented, and the company's core capacity building has been greatly delayed in the layers of outsourcing. Next, our team members must raise the dimension in thought, get close to the front line of the business in action, return to the front line of the business, and hear the fire of the front line battle. Zhao Yan proposed that those who do not have the ability to produce specific results in front-line work should be transferred to the job for training, and those who should be eliminated should be eliminated; Those who do not understand the details of front-line work, will only convey transfers, and engage in pseudo-organizational work, will be eliminated. "Don't use any performance fluctuations to blackmail the company's determination to tighten outsourcing, reducing the expense ratio is only a superficial problem, and cultivating long-term competitiveness for the organization is a more long-term consideration."

Zhao Yan said that Bloomage Biotech wants to return to the entrepreneurial organization, and the next step is to break the pseudo-work of the inefficient bureaucratic team, re-establish the entrepreneurial organization, and re-cultivate the entrepreneurial team spirit. At the same time, she also asked all corrupt personnel in the company, regardless of their positions, to explain their problems and submit their resignations within a time limit.

"In view of the relaxed atmosphere before the management of the enterprise, there are a lot of internal problems, this year the company has begun to scrape the bones to cure the poison, we will not tolerate the historical problems of indulgence, all corrupt personnel regardless of their positions, must be within March 31 to explain the problem, submit a resignation." Zhao Yan demanded that if he did not take the initiative to confess after the time limit, he would be handed over to the judicial department and not dealt with internally.

Zhao Yan also emphasized that staying away from those excuses and complaints, any complaint about the environment instead of reflecting on oneself will lead to a loss of depth in looking at the world and will only make oneself a failure. "I'm an entrepreneur, I worked all the way from scratch, don't think that I have a little power in my hands, I can create some chaos, and I can also make my performance fluctuate, I will take it seriously."

In the future, we will keep up with the trend of AI transformation

A few days ago, Bloomage Biotech released its 2024 annual performance report, showing that the company's total operating income was about 5.37 billion yuan, a year-on-year decrease of 11.6%; The net profit was about 164 million yuan, a year-on-year decrease of 72.27%. As for the reasons for the change in performance, Bloomage Biotech said that the company's functional skin care products business, which accounts for a high proportion of revenue, is affected by various factors such as intensified market competition, industrial cycle fluctuations and strategic adjustments.

Bloomage Biotech also said that the company adheres to and continues to implement management reform and promote the implementation of management reform projects. Due to the upgrading of the organizational structure, the reform of the salary system, the cost of consulting companies and equity incentive expenses of more than 70 million yuan, the management change has brought a certain short-term cost increase, but it has laid a solid foundation for the company's long-term development. In addition, the company continued to increase its investment in innovative business areas, with more than 100 million yuan invested in strategic innovation business.

In addition to the above impacts, asset impairment is also an important factor in the decline of Bloomage Biotech's net profit attributable to its parent company. Bloomage Biotech mentioned that in accordance with the "Accounting Standards for Business Enterprises" and the relevant provisions of the company's accounting policies and accounting estimates, in order to truly and accurately reflect the company's financial position and operating results as of the current reporting period, in line with the principle of prudence, the company has conducted impairment tests on accounts receivable, inventory, goodwill and other assets, and has made a large impairment provision of about 190 million yuan for related assets with signs of impairment.

Regarding the performance pressure faced by the company, Zhao Yan also attributed organizational problems in this speech. "Part of this adjustment is caused by the market, and a bigger part is because I realized that our organization and talents have not kept up with the changes of the times and took the initiative to step on the brakes."

In Zhao Yan's view, in the next 10 years, the global life sciences will develop dramatically with the empowerment of AI, and the customer acquisition and consumer decision-making links of the consumer goods business will also undergo great changes. "Whoever doesn't follow this trend to establish an organization to cultivate talents, and is still making some money, engaging in small group interests, and playing clever games, will give me a lesson."

Zhao Yan pointed out that in the future, the decision-making chain, brand building and customer acquisition model of life sciences will undergo great changes in the raw material business, consumer medical business, and brand operation business, and Bloomage must follow this trend to establish new organizations and cultivate new talents.

In addition, according to the article, according to Zhao Yan's proposal, the original "Personal Health Consumer Products Division" of Bloomage Biotech will be renamed as "Skin Science Innovation and Transformation Division", and the organization and business adjustment of the department will be carried out.

At present, the latest market value of Bloomage Biotech is 23.7 billion yuan.